Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

1.

Pathophysiology of hypertension: interactions between macro and microvascular alterations through endothelial dysfunction.

Yannoutsos A, Levy BI, Safar ME, Slama G, Blacher J.

J Hypertens. 2014 Feb;32(2):216-24. doi: 10.1097/HJH.0000000000000021.

PMID:
24270179
[PubMed - in process]
2.

Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes.

Wessman M, Forsblom C, Kaunisto MA, Söderlund J, Ilonen J, Sallinen R, Hiekkalinna T, Parkkonen M, Maxwell AP, Tarnow L, Parving HH, Hadjadj S, Marre M, Peltonen L, Groop PH; FinnDiane Study Group.

PLoS One. 2011;6(9):e24053. doi: 10.1371/journal.pone.0024053. Epub 2011 Sep 1.

PMID:
21909410
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.

Vigeral C, Sola-Gazagnes A, Nejjar S, M'Bemba J, Boitard C, Slama G, Elgrably F, Larger E.

Diabetes Metab. 2011 Dec;37(6):553-9. doi: 10.1016/j.diabet.2011.06.002. Epub 2011 Jul 28.

PMID:
21802332
[PubMed - indexed for MEDLINE]
Free Article
4.

A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients.

Schaepelynck P, Renard E, Jeandidier N, Hanaire H, Fermon C, Rudoni S, Catargi B, Riveline JP, Guerci B, Millot L, Martin JF, Sola A; EVADIAC Group.

Diabetes Technol Ther. 2011 Jun;13(6):657-60. doi: 10.1089/dia.2010.0209. Epub 2011 Apr 6.

PMID:
21470000
[PubMed - indexed for MEDLINE]
5.

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study.

Pfister R, Cairns R, Erdmann E, Schneider CA; PROactive investigators.

Diabet Med. 2011 Oct;28(10):1206-12. doi: 10.1111/j.1464-5491.2011.03281.x.

PMID:
21388447
[PubMed - indexed for MEDLINE]
6.

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials.

Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, Fuller JH, Klein R, Orchard T, Parving HH, Sjølie AK; DIRECT Study Group.

Diabetologia. 2011 Jun;54(6):1298-303. doi: 10.1007/s00125-010-2040-1. Epub 2011 Jan 12.

PMID:
21225239
[PubMed - indexed for MEDLINE]
7.

Therapeutic alliance and glycaemic control in type 1 diabetes: a pilot study.

Attale C, Lemogne C, Sola-Gazagnes A, Guedeney N, Slama G, Horvath AO, Consoli SM.

Diabetes Metab. 2010 Dec;36(6 Pt 1):499-502. doi: 10.1016/j.diabet.2010.08.003. Epub 2010 Oct 8.

PMID:
20934364
[PubMed - indexed for MEDLINE]
Free Article
8.

Peak-time determination of post-meal glucose excursions in insulin-treated diabetic patients.

Daenen S, Sola-Gazagnes A, M'Bemba J, Dorange-Breillard C, Defer F, Elgrably F, Larger E, Slama G.

Diabetes Metab. 2010 Apr;36(2):165-9. doi: 10.1016/j.diabet.2009.12.002. Epub 2010 Mar 11.

PMID:
20226708
[PubMed - indexed for MEDLINE]
Free Article
9.

Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients.

Laaban JP, Daenen S, Léger D, Pascal S, Bayon V, Slama G, Elgrably F.

Diabetes Metab. 2009 Nov;35(5):372-7. doi: 10.1016/j.diabet.2009.03.007. Epub 2009 Aug 15.

PMID:
19683953
[PubMed - indexed for MEDLINE]
Free Article
10.

Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres.

Chabouis A, Berdugo M, Meas T, Erginay A, Laloi-Michelin M, Jouis V, Guillausseau PJ, M'bemba J, Chaine G, Slama G, Cohen R, Reach G, Marre M, Chanson P, Vicaut E, Massin P.

Diabetes Metab. 2009 Jun;35(3):228-32. doi: 10.1016/j.diabet.2008.12.001. Epub 2009 Apr 5.

PMID:
19349202
[PubMed - indexed for MEDLINE]
Free Article
11.

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Chaturvedi N; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1385-93. doi: 10.1016/S0140-6736(08)61411-7. Epub 2008 Sep 25.

PMID:
18823658
[PubMed - indexed for MEDLINE]
Free Article
12.

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, Bilous R, Sjølie AK; DIRECT Programme Study Group.

Lancet. 2008 Oct 18;372(9647):1394-402. doi: 10.1016/S0140-6736(08)61412-9. Epub 2008 Sep 25.

PMID:
18823656
[PubMed - indexed for MEDLINE]
13.

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies.

Berger R, Rotem-Yehudar R, Slama G, Landes S, Kneller A, Leiba M, Koren-Michowitz M, Shimoni A, Nagler A.

Clin Cancer Res. 2008 May 15;14(10):3044-51. doi: 10.1158/1078-0432.CCR-07-4079.

PMID:
18483370
[PubMed - indexed for MEDLINE]
Free Article
14.

[Apollinaire Bouchardat and diabetes].

Chast F, Slama G.

Hist Sci Med. 2007 Jul-Sep;41(3):287-301. French.

PMID:
18348493
[PubMed - indexed for MEDLINE]
15.

[One-year follow-up in real clinical practice conditions of type 2 diabetic patients treated with rosiglitazone: the Avantage study].

Slama G, Eschwège E, Bernard MH, Grimaldi A, Oppert JM, Pouchain D, Bégaud B; pour le groupe des investigateurs de l'étude Avantage.

Ann Endocrinol (Paris). 2008 Feb;69(1):36-46. doi: 10.1016/j.ando.2007.10.024. Epub 2008 Feb 20. French.

PMID:
18243155
[PubMed - indexed for MEDLINE]
16.

Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study.

Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S, Quignard-Boulangé A, Vidal H, Slama G, Clément K, Guerre-Millo M, Rizkalla SW.

Am J Clin Nutr. 2007 Dec;86(6):1670-9.

PMID:
18065585
[PubMed - indexed for MEDLINE]
Free Article
17.

A review of the metabolic syndrome.

Balkau B, Valensi P, Eschwège E, Slama G.

Diabetes Metab. 2007 Dec;33(6):405-13. Epub 2007 Nov 5. Review.

PMID:
17981485
[PubMed - indexed for MEDLINE]
Free Article
19.

Motivational effects of 12-week moderately restrictive diets with or without special attention to the Glycaemic Index of foods.

Bellisle F, Dalix AM, De Assis MA, Kupek E, Gerwig U, Slama G, Oppert JM.

Br J Nutr. 2007 Apr;97(4):790-8.

PMID:
17349094
[PubMed - indexed for MEDLINE]
20.

Type I and type IV allergy to the insulin analogue detemir.

Sola-Gazagnes A, Pecquet C, M'Bemba J, Larger E, Slama G.

Lancet. 2007 Feb 24;369(9562):637-8. No abstract available.

PMID:
17321300
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk